Metfendrazine
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C10H16N2 |
| Molar mass | 164.252 g·mol−1 |
Metfendrazine (HM-11, MO-482), also known as methphendrazine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class.[1][2] It was investigated as an antidepressant, but was never marketed.
See also
References
- ↑ Miquel J, Mijan CD (1962). "Metfendrazine, a new inhibitor of monoamine oxidase". Archivos del Instituto de Farmacología Experimental. 14. Madrid: 47–59.
- ↑ Kothari NJ, Saunders JC, Kline NS, Griffen JA (October 1960). "A comparison of perphenazine, proketazine, nialamide and MO-482 in chronic schizophrenics". The American Journal of Psychiatry. 117 (4): 358–360. doi:10.1176/ajp.117.4.358. PMID 13753478.
| 5-HT1ARTooltip 5-HT1A receptor agonists | |
|---|---|
| GABAARTooltip GABAA receptor PAMsTooltip positive allosteric modulators |
|
| Hypnotics | |
| Gabapentinoids (α2δ VDCC blockers) | |
| Antidepressants |
|
| Antipsychotics | |
| Sympatholytics (Antiadrenergics) |
|
| Others | |
| |
| Non-specific |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phenethylamines (dopamine, epinephrine, norepinephrine) |
| ||||||||||
| Tryptamines (serotonin, melatonin) |
| ||||||||||
| Histamine |
| ||||||||||
See also: Receptor/signaling modulators • Adrenergics • Dopaminergics • Melatonergics • Serotonergics • Monoamine reuptake inhibitors • Monoamine releasing agents • Monoamine neurotoxins | |||||||||||
Hydrazines | |
|---|---|
|
This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.